Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm ‌ Ghayas C. Issa, Courtney D. DiNardo

Ստացեք ամբողջական տեքստը

A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults ‌ R. Bou Serhal, P. Salameh, N. Wakim, C. Issa, B. Kassem, L. Abou Jaoude, N. Saleh

Ստացեք ամբողջական տեքստը

Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia ‌ Aram Bidikian, Hagop Kantarjian, Elias Jabbour, Nicholas J. Short, Keyur Patel, Farhad Ravandi, Koji Sasaki, Ghayas C. Issa

Ստացեք ամբողջական տեքստը

Management of chronic myeloid leukemia in 2023 – common ground and common sense ‌ Jayastu Senapati, Koji Sasaki, Ghayas C. Issa, Jeffrey H. Lipton, Jerald P. Radich, Elias Jabbour, Hagop M. Kantarjian

Ստացեք ամբողջական տեքստը

REUSING STOCKS SOLUTIONS WITH DIFFERENT FORMULATED FOR ORCHID FERTILIZER ACCLIMATIZATION PHASE ‌ C. G. C. Issa, W. J. Pereira, A. C. F. Miranda, R. C. Felicio, A. R. Silva, M. C. Vieira

Ստացեք ամբողջական տեքստը

Reusing stocks solutions with different formulated for orchid fertilizer acclimatization phase ‌ C. G. C. Issa, W. J. Pereira, A. C. F. Miranda, R. C. Felicio, A. R. Silva, M. C. Vieira

Ստացեք ամբողջական տեքստը

Nontuberculosis mycobacteria (NTM) infections in patients with leukemia: a single center case series ‌ Jennifer Marvin-Peek, Koji Sasaki, Dimitrios P. Kontoyiannis, Javier Adachi, Maro Ohanian, Koichi Takahashi, Ghayas C. Issa, Steven Kornblau, Hussein A. Abbas, Hussein A. Abbas

Ստացեք ամբողջական տեքստը

Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation ‌ Matthew P. Cheng, Alisha Pandit, Joseph H. Antin, Stephen R. Walsh, Daisy Huynh, Irene M. Ghobrial, Lindsey R. Baden, Francisco M. Marty, Nicolas C. Issa

Ստացեք ամբողջական տեքստը

Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemia ‌ Iman Abou Dalle, Ronald Paranal, Jabra Zarka, Shilpa Paul, Koji Sasaki, Wen Li, Jing Ning, Nicholas J. Short, Maro Ohanian, Jorge E. Cortes, Elias J. Jabbour, Ghayas C. Issa

Ստացեք ամբողջական տեքստը

Calibration-free NGS quantitation of mutations below 0.01% VAF ‌ Peng Dai, Lucia Ruojia Wu, Sherry Xi Chen, Michael Xiangjiang Wang, Lauren Yuxuan Cheng, Jinny Xuemeng Zhang, Pengying Hao, Weijie Yao, Jabra Zarka, Ghayas C. Issa, Lawrence Kwong, David Yu Zhang

Ստացեք ամբողջական տեքստը

Myeloid lineage switch in <i>KMT2A-</i>rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies ‌ Alex Bataller, Tareq Abuasab, David McCall, Wei Wang, Branko Cuglievan, Ghayas C. Issa, Elias Jabbour, Nicholas Short, Courtney D. DiNardo, Guilin Tang, Guillermo Garcia-Manero, Hagop M. Kantarjian, Koji Sasaki

Ստացեք ամբողջական տեքստը

P561: REVUMENIB IN PATIENTS WITH ACUTE LEUKEMIAS: COMPASSIONATE USE PROGRAM EXPERIENCE ‌ Jeffrey Rubnitz, Ghayas C. Issa, Eytan M. Stein, Neerav Shukla, Wendy Stock, Andrius Žučenka, Sajad Khazal, Nandita Khera, Elliot Stieglitz, Jeremy Rubinstein, Galit Rosen, Rachel Ghiraldi, Huy Van Nguyen, Nicole Mcneer, C. Michel Zwaan

Ստացեք ամբողջական տեքստը

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series ‌ Ahmad S. Alotaibi, Musa Yilmaz, Sanam Loghavi, Courtney DiNardo, Gautam Borthakur, Tapan M. Kadia, Beenu Thakral, Naveen Pemmaraju, Ghayas C. Issa, Marina Konopleva, Nicholas J. Short, Keyur Patel, Guilin Tang, Farhad Ravandi, Naval Daver

Ստացեք ամբողջական տեքստը

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience ‌ Kamal Chamoun, Hagop Kantarjian, Rami Atallah, Graciela Nogueras Gonzalez, Ghayas C. Issa, Mary Beth Rios, Guillermo Garcia-Manero, Gautam Borthakur, Farhad Ravandi, Nitin Jain, Naval Daver, Marina Konopleva, Courtney D. DiNardo, Tapan Kadia, Naveen Pemmaraju, Elias Jabbour, Jorge Cortes

Ստացեք ամբողջական տեքստը

P576: A PHASE I/II STUDY OF MILADEMETAN (DS3032B) IN COMBINATION WITH LOW DOSE CYTARABINE WITH OR WITHOUT VENETOCLAX IN ACUTE MYELOID LEUKEMIA ‌ J. Senapati, J. Ishizawa, H. A. Abbas, S. Loghavi, G. Borthakur, G. C. Issa, S. I. Dara, R. Pourebrahim, N. Daver, E. J. Jabbour, S. M. Kornblau, N. Pemmaraju, G. Garcia-Manero, F. Ravandi, M. Muftuoglu, J. Khoury, C. DiNardo, M. Andreeff

Ստացեք ամբողջական տեքստը

Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy ‌ Wei-Ying Jen, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia, Sa A. Wang, Wei Wang, Sanam Loghavi, Naval G. Daver, Courtney D. DiNardo, Ghayas C. Issa, Hussein A. Abbas, Cedric Nasnas, Alex Bataller, Samuel Urrutia, Omer S. Karrar, Sherry Pierce, Hagop M. Kantarjian, Nicholas J. Short

Ստացեք ամբողջական տեքստը

Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements ‌ Ghayas C. Issa, Jabra Zarka, Koji Sasaki, Wei Qiao, Daewoo Pak, Jing Ning, Nicholas J. Short, Fadi Haddad, Zhenya Tang, Keyur P. Patel, Branko Cuglievan, Naval Daver, Courtney D. DiNardo, Elias Jabbour, Tapan Kadia, Gautam Borthakur, Guillermo Garcia-Manero, Marina Konopleva, Michael Andreeff, Hagop M. Kantarjian, Farhad Ravandi

Ստացեք ամբողջական տեքստը

P566: IMPACT OF FRONTLINE INDUCTION APPROACH ON POST-STEM CELL TRANSPLANT (SCT) OUTCOMES IN OLDER ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) ‌ F. Ong, F. Ravandi, U. Popat, T. M. Kadia, N. Daver, C. DiNardo, M. Konopleva, G. Borthakur, E. J. Shpall, B. Oran, G. Al-Atrash, R. Mehta, E. J. Jabbour, M. Yilmaz, G. C. Issa, G. Garcia-Manero, A. Maiti, H. A. Abbas, R. E. Champlin, N. J. Short

Ստացեք ամբողջական տեքստը

Outcomes and genetic dynamics of acute myeloid leukemia at first relapse ‌ Alex Bataller, Hagop Kantarjian, Alexandre Bazinet, Tapan Kadia, Naval Daver, Courtney D. DiNardo, Gautam Borthakur, Sanam Loghavi, Keyur Patel, Guilin Tang, Koji Sasaki, Nicholas J. Short, Musa Yilmaz, Ghayas C. Issa, Yesid Alvarado, Guillermo Montalban-Bravo, Abhishek Maiti, Hussein A. Abbas, Koichi Takahashi, Sherry Pierce, Elias Jabbour, Guillermo Garcia-Manero, Farhad Ravandi

Ստացեք ամբողջական տեքստը

Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure ‌ Nicholas J. Short, Sangeetha Venugopal, Wei Qiao, Tapan M. Kadia, Farhad Ravandi, Walid Macaron, Courtney D. Dinardo, Naval Daver, Marina Konopleva, Gautam Borthakur, Elizabeth J. Shpall, Uday Popat, Richard E. Champlin, Rohtesh Mehta, Gheath Al-Atrash, Betul Oran, Elias Jabbour, Guillermo Garcia-Manero, Ghayas C. Issa, Guillermo Montalban-Bravo, Musa Yilmaz, Abhishek Maiti, Hagop Kantarjian

Ստացեք ամբողջական տեքստը